UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance to Therapy in Acute Promyelocytic Leukemia

The New England journal of medicine, 2014-09, Vol.371 (12), p.1170-1172

2014

Volltextzugriff (PDF)

Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1641-1646

2012

Volltextzugriff (PDF)

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)

Leukemia research, 2013-06, Vol.37 (6), p.637-640

2013

Volltextzugriff (PDF)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia

Nature communications, 2018-05, Vol.9 (1), p.2047-8, Article 2047

2018

Volltextzugriff (PDF)

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

Haematologica (Roma), 2019-08, Vol.104 (8), p.1565-1571

2019

Volltextzugriff (PDF)

Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-07, Vol.30 (4), p.981-987

2024

Volltextzugriff (PDF)

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient

Haematologica (Roma), 2021-05, Vol.106 (8), p.2287-2290

2021

Volltextzugriff (PDF)

Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study

Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2697-2699

2022

Volltextzugriff (PDF)

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.554-557

2024

Volltextzugriff (PDF)

Emicizumab and asparaginase, A first experience to share

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.561-563

2024

Volltextzugriff (PDF)

NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents

Haematologica (Roma), 2018-10, Vol.103 (10), p.e455-e457

2018

Volltextzugriff (PDF)

Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast‐like synoviocytes

Journal of cellular and molecular medicine, 2020-12, Vol.24 (24), p.14453-14466

2020

Volltextzugriff (PDF)

Emicizumab does not interfere with the activated clotting time

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.362-366

2022

Volltextzugriff (PDF)

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-07, Vol.27 (4), p.e581-e584

2021

Volltextzugriff (PDF)

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine

Annals of hematology, 2018-03, Vol.97 (3), p.541-542

2018

Volltextzugriff (PDF)

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients

British journal of haematology, 2020-08, Vol.190 (3), p.461-464

2020

Volltextzugriff (PDF)

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia

Leukemia, 2018-09, Vol.32 (9), p.2066-2069

2018

Volltextzugriff (PDF)

Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1661-1664

2023

Volltextzugriff (PDF)

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

Leukemia research, 2014-07, Vol.38 (7), p.751-755

2014

Volltextzugriff (PDF)

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

Leukemia, 2024-08

2024

Volltextzugriff (PDF)

Current Treatments Do Not Improve the Prognosis of Patients with Atypical CML and Unclassified MDS/MPN. a Joint Report from Fi-LMC, FIM, Gfch and GFM

Blood, 2019-11, Vol.134 (Supplement_1), p.2954-2954

2019

Volltextzugriff (PDF)

Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes

Leukemia research, 2015-11, Vol.39 (11), p.1214-1219

2015

Volltextzugriff (PDF)

Synergistic effects of PRIMA-1 Met (APR-246) and 5-azacitidine in TP53 -mutated myelodysplastic syndromes and acute myeloid leukemia

Haematologica (Roma), 2020-06, Vol.105 (6), p.1539-1551

2020

Volltextzugriff (PDF)

Systematic search for the UBA1 mutation in men after a first venous thrombotic episode

Archives of cardiovascular diseases supplements, 2023-05, Vol.15 (2), p.182-183

2023

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(48)
Berichte
(4)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Life Sciences
(19)
Hematology
(18)
Humans
(16)
Male
(10)
Human Health And Pathology
(8)
Oncology
(8)
Cancer
(6)
Female
(6)
Acute Promyeloid Leukemia
(4)
Adult
(4)
Antimetabolites, Antineoplastic - Therapeutic Use
(4)
Azacitidine - Therapeutic Use
(4)
Hemophilia
(4)
Leukemia
(4)
Leukemia, Myeloid, Acute - Drug Therapy
(4)
Middle Aged
(4)
Mutation
(4)
Myelodysplastic Syndromes - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Resistance to Therapy in Acute Promyelocytic Leukemia

Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient

Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Emicizumab and asparaginase, A first experience to share

NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents

Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast‐like synoviocytes

Emicizumab does not interfere with the activated clotting time

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia

Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

Current Treatments Do Not Improve the Prognosis of Patients with Atypical CML and Unclassified MDS/MPN. a Joint Report from Fi-LMC, FIM, Gfch and GFM

Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes

Synergistic effects of PRIMA-1 Met (APR-246) and 5-azacitidine in TP53 -mutated myelodysplastic syndromes and acute myeloid leukemia

S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME HARBORING DEL(5Q). A HARMONY ALLIANCE STUDY

Systematic search for the UBA1 mutation in men after a first venous thrombotic episode

Suchergebnisse filtern